Adjusted odds ratios (OR) of clinical parameters included for most accurate designation of subjects discontinuing treatment due to pulmonary adverse effects.
Abstract
Adjusted odds ratios (OR) of clinical parameters included for most accurate designation of subjects discontinuing treatment due to pulmonary adverse effects.</p- Dataset
- Dataset
- Biochemistry
- Medicine
- Microbiology
- Cell Biology
- Genetics
- Pharmacology
- Biotechnology
- Immunology
- Cancer
- Infectious Diseases
- Plant Biology
- Virology
- Chemical Sciences not elsewhere classified
- lung function
- fibrosis transmembrane conductance regulator
- leukocyte surface antigens
- CXCR 2 levels
- F 508del CFTR mutation Cystic fibrosis
- F 508del mutation
- discontinuation
- potentiates CFTR function
- Colorado Adult CF Program
- luma
- treatment initiation